4.5 Review

Controlling amyloid formation of intrinsically disordered proteins and peptides: slowing down or speeding up?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

Molecular Basis of Small-Molecule Binding to alpha-Synuclein

Paul Robustelli et al.

Summary: This study used molecular dynamics simulations to investigate the binding of a small-molecule drug to an intrinsically disordered protein associated with Parkinson's disease. The simulations revealed a dynamic shuttling mechanism of certain charge-charge and pi-stacking interactions during the binding process. Subsequent experiments confirmed the potential for designing small molecules that effectively bind with disordered proteins.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Article Multidisciplinary Sciences

Soluble TREM2 inhibits secondary nucleation of A13 fibrillization and enhances cellular uptake of fibrillar A13

Ketaki D. Belsare et al.

Summary: The soluble form of TREM2, sTREM2, was found to bind to fibrillar A1340 and A1342, enhancing their uptake into cells. sTREM2 inhibited the secondary nucleation step in A13 fibrillization, but had little effect on the primary nucleation pathway. The disease-associated mutant R47H showed reduced uptake and functional responses to fibrils. Molecular modeling revealed the binding mode of sTREM2 to A13 fibrils.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Clinical Neurology

Quantifying regional α-synuclein, amyloid β, and tau accumulation in lewy body dementia

Rebecca L. Miller et al.

Summary: This study investigated the accumulation of alpha-synuclein (alpha-syn), amyloid beta (A beta), and tau in individuals with Parkinson's disease and Lewy body dementia. The results showed widespread accumulation of insoluble alpha-syn in Lewy body dementia cases, with higher levels correlating with the severity of dementia. Some cases exhibited lower levels of alpha-syn in the neocortex, suggesting additional factors contribute to impaired function. The presence of A beta was associated with greater alpha-syn accumulation, while tau accumulation was only observed in one case. These findings highlight the pathophysiological relationship between A beta and alpha-syn in Lewy body dementia.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2022)

Article Biochemistry & Molecular Biology

Silybins inhibit human IAPP amyloid growth and toxicity through stereospecific interactions

Sara Garcia-Vinuales et al.

Summary: Silybin B, a natural diastereoisomer, has shown potential in inhibiting IAPP aggregation and protecting cells from its toxicity. Molecular dynamics simulations have revealed the importance of its interactions with specific regions of IAPP. These findings provide insights for designing more efficient Silybin derivatives in the future.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2022)

Article Chemistry, Medicinal

A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors

Laszlo Petri et al.

Summary: In this study, a covalent design strategy targeting intrinsically disordered proteins (IDPs) was developed based on the promising results of targeted covalent inhibitors (TCIs) on challenging targets. Using tau protein as a model system, suitable warheads were introduced to non-covalent scaffolds of potential tau aggregation inhibitors. The designed covalent tau binders effectively inhibited tau aggregation in aggregation models, providing promising candidates for the treatment of tauopathies.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin

Ricarda Torner et al.

Summary: Integrated kinetic and structural investigations reveal that the co-chaperonin prefoldin interacts with islet amyloid polypeptide fibrils to inhibit their elongation and secondary nucleation.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Foldamers reveal and validate therapeutic targets associated with toxic α-synuclein self-assembly

Jemil Ahmed et al.

Summary: Inhibiting the self-assembly of alpha-synuclein into amyloid structures is a potential therapeutic strategy for Parkinson's disease. This study identifies the essential domains/sequences involved in alpha-synuclein aggregation and tests the effectiveness of foldamer-based antagonists as potential therapeutic targets. The findings provide valuable insights into alpha-synuclein aggregation and have significant implications for the development of effective treatments for Parkinson's disease.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

Yong Xu et al.

Summary: This study applied chemical kinetics to investigate the assembly mechanism of hIAPP and discovered two small-molecule modulators that can regulate hIAPP assembly, which can serve as promising starting-points for research on hIAPP aggregation and the development of therapeutics for T2D.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Visualizing and trapping transient oligomers in amyloid assembly pathways

Emma E. Cawood et al.

Summary: Understanding the formation and toxicity mechanisms of oligomers during amyloid fibril assembly is crucial for amyloid diseases. By utilizing methods such as NMR, mass spectrometry, and tools to manipulate the amyloid energy landscape, researchers can gain insights into the nature and role of these oligomeric intermediates. These approaches allow for the study of kinetics, structural information, and structure-toxicity relationships of oligomers, providing a clearer picture of their contribution to amyloid formation and disease.

BIOPHYSICAL CHEMISTRY (2021)

Review Chemistry, Multidisciplinary

Proteostasis of Islet Amyloid Polypeptide: A Molecular Perspective of Risk Factors and Protective Strategies for Type II Diabetes

Danilo Milardi et al.

Summary: The possible link between hIAPP accumulation and beta-cell death in diabetic patients has sparked a lot of research on amyloid structures and aggregation pathways. Recent studies have highlighted the importance of early oligomeric intermediates and their interactions with lipid membranes, pH, insulin, and zinc in the mechanism of hIAPP aggregation. Challenges in characterizing the aggregation process have led to the development of various biophysical and chemical approaches, with studies suggesting that restoring hIAPP proteostasis could be a promising strategy for therapy.

CHEMICAL REVIEWS (2021)

Review Biochemistry & Molecular Biology

An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure

Subramanian Boopathi et al.

Summary: Understanding the aggregation and toxicity pathways of Aβ oligomers is crucial for developing therapeutic strategies for Alzheimer's disease, computer simulation can aid experimental studies in mapping the generation mechanism of Aβ, and currently there is no good drug candidate available for clinical treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Chemistry, Multidisciplinary

Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis

Phuong H. Nguyen et al.

Summary: Protein misfolding and aggregation are common in amyloidogenic diseases, and understanding how amyloid species become toxic is crucial for treatment development. Experiments using computer modeling, in vitro and in vivo studies, as well as pharmacology, have provided valuable insights into the accumulation and deposition of amyloid species, contributing to research on diseases like Alzheimer's, Parkinson's, diabetes, and ALS.

CHEMICAL REVIEWS (2021)

Article Biochemistry & Molecular Biology

A new biological prospective for the 2-phenylbenzofurans as inhibitors of α-glucosidase and of the islet amyloid polypeptide formation

Giovanna Lucia Delogu et al.

Summary: The study found that hydroxylated 2-phenylbenzofurans compounds exhibited strong inhibitory activity against alpha-glucosidase, with compound 16 showing the best performance. It also effectively inhibited IAPP aggregation without significant cytotoxicity.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Multidisciplinary Sciences

Structure-based classification of tauopathies

Yang Shi et al.

Summary: The structures of tau filaments from different tauopathies vary, allowing for a hierarchical classification of these diseases. Some tauopathies share similar filament folds, while others have distinct folding patterns.

NATURE (2021)

Article Plant Sciences

Synthesis of Yakuchinone B-Inspired Inhibitors against Islet Amyloid Polypeptide Aggregation

Jui-Yi Hsu et al.

Summary: Type 2 diabetes mellitus is linked to pancreatic beta-cell dysfunction and insulin resistance, with islet amyloid polypeptide aggregation leading to beta-cell death. Certain compounds have been found to inhibit IAPP aggregation, with compounds 4g and 4h showing significant protection against IAPP-induced toxicity in beta-cells.

JOURNAL OF NATURAL PRODUCTS (2021)

Review Chemistry, Multidisciplinary

Quantifying misfolded protein oligomers as drug targets and biomarkers in Alzheimer and Parkinson diseases

Klara Kulenkampff et al.

Summary: Protein misfolding and aggregation are characteristic of neurodegenerative disorders, with misfolded protein oligomers recognized as the main agents causing pathological processes. Challenges in detecting and quantifying these oligomers have hindered research on developing diagnostic and therapeutic tools.

NATURE REVIEWS CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Repurposing a Cardiovascular Disease Drug of Cloridarol as hIAPP Inhibitor

Yijing Tang et al.

Summary: There is a strong pathological correlation between cardiovascular disease (CVD) and Type II diabetes (T2D), both of which share common risk factors. The study proposed repurposing a CVD drug, cloridarol, as a human islet amyloid peptide (hIAPP) inhibitor to prevent abnormal misfolding and aggregation in T2D. Experimental and computational approaches confirmed the inhibitory activity of cloridarol on hIAPP aggregation and toxicity, providing a potential new treatment approach.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium

George R. Nahass et al.

Summary: Brazilin has been shown to inhibit the fibril formation of α-syn by altering conformational equilibria, eliminate seeding competence of α-syn assemblies from Parkinson's disease patient brain tissue, and reduce toxicity by inducing the formation of large fibril clusters. These findings suggest that Brazilin has substantial potential as a neuroprotective and therapeutic agent for Parkinson's disease.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates

Diana C. Rodriguez Camargo et al.

Summary: The aggregation of human islet amyloid polypeptide (IAPP) is associated with type II diabetes, with IAPP oligomers identified as the most cytotoxic species. Secondary nucleation is the main mechanism for generating new aggregates, with toxicity peaking at the maximum secondary nucleation rate. Compounds targeting IAPP secondary nucleation may be the most effective therapeutic candidates for type II diabetes.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Nanoscience & Nanotechnology

Surface Plasmon Resonance Assay for Identification of Small Molecules Capable of Inhibiting Aβ Aggregation

Jeeyeon Lee et al.

Summary: The study introduced a simple and rapid surface plasmon resonance (SPR) assay method for identifying potential A beta aggregation inhibitors, which can be a powerful tool for high-throughput screening.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Biochemistry & Molecular Biology

Identification of ortho catechol-containing isoflavone as a privileged scaffold that directly prevents the aggregation of both amyloid β plaques and tau-mediated neurofibrillary tangles and its in vivo evaluation

Seung Hwan Son et al.

Summary: Polyhydroxyisoflavones synthesized in this study effectively prevented the aggregation of both amyloid beta and tau, with an ortho-catechol containing isoflavone scaffold proving crucial for this prevention. Further analysis indicated that the compound could directly inhibit the formation of A beta fibrils and tau-derived neurofibrils, potentially through catechol-mediated nucleation of tau. Additionally, the compound was shown to alleviate cognitive impairment and pathologies related to Alzheimer's disease in a transgenic mouse model.

BIOORGANIC CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Intrinsically disordered proteins and biomolecular condensates as drug targets

Mateusz Biesaga et al.

Summary: Intrinsically disordered domains are attractive therapeutic targets in cancer, neurodegenerative, and infectious diseases, despite being considered undruggable. Recent findings suggest that biomolecular condensation processes can offer opportunities for modulating the activities of intrinsically disordered targets in a different environment from their surrounding solutions.

CURRENT OPINION IN CHEMICAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Effects of lithospermic acid on hIAPP aggregation and amyloid-induced cytotoxicity by multiple analytical methods

Bo Pang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)

Review Chemistry, Multidisciplinary

Peptide-Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration

Valentina Armiento et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Article Biochemistry & Molecular Biology

Polyphenolic Biflavonoids Inhibit Amyloid-Beta Fibrillation and Disaggregate Preformed Amyloid-Beta Fibrils

Erika Y. Choi et al.

BIOMOLECULES & THERAPEUTICS (2020)

Article Biochemistry & Molecular Biology

Kinetic Control of Amyloidogenesis Calls for Unconventional Drugs To Fight Alzheimer's Disease

Amedeo Caflisch

ACS CHEMICAL NEUROSCIENCE (2020)

Review Biochemistry & Molecular Biology

Amyloid structures: much more than just a cross-β fold

Rodrigo Gallardo et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Using protein engineering to understand and modulate aggregation

Jessica S. Ebo et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

High-Throughput Screening at the Membrane Interface Reveals Inhibitors of Amyloid-β

Sarah J. Cox et al.

BIOCHEMISTRY (2020)

Review Chemistry, Medicinal

Non-polyphenolic natural inhibitors of amyloid aggregation

Liang Ma et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Neurosciences

Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease

Ana F. Raimundo et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)

Review Biochemistry & Molecular Biology

Targeting Intrinsically Disordered Proteins through Dynamic Interactions

Jianlin Chen et al.

BIOMOLECULES (2020)

Article Biochemistry & Molecular Biology

Tetracycline derivatives resist the assembly behavior of human islet amyloid polypeptide

Jufei Xu et al.

BIOCHIMIE (2020)

Article Biochemistry & Molecular Biology

Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils

Qin Cao et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies

Sara Linse et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Therapeutic Strategies to Reduce the Toxicity of Misfolded Protein Oligomers

Ryan P. Kreiser et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Multidisciplinary

Modulation of Amyloidogenic Protein Self-Assembly Using Tethered Small Molecules

Emma E. Cawood et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)

Article Materials Science, Multidisciplinary

Aromadendrin: a dual amyloid promoter to accelerate fibrillization and reduce cytotoxicity of both amyloid-β and hIAPP

Yanxian Zhang et al.

MATERIALS ADVANCES (2020)

Article Nanoscience & Nanotechnology

Introduction and Fundamentals of Human Islet Amyloid Polypeptide Inhibitors

Yijing Tang et al.

ACS APPLIED BIO MATERIALS (2020)

Article Multidisciplinary Sciences

Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer's disease

Gabriella T. Heller et al.

SCIENCE ADVANCES (2020)

Article Multidisciplinary Sciences

Molecular dissection of amyloid disaggregation by human HSP70

Anne S. Wentink et al.

NATURE (2020)

Article Chemistry, Multidisciplinary

Small molecule induced toxic human-IAPP species characterized by NMR

Sarah J. Cox et al.

CHEMICAL COMMUNICATIONS (2020)

Review Chemistry, Multidisciplinary

Half a century of amyloids: past, present and future

Pu Chun Ke et al.

CHEMICAL SOCIETY REVIEWS (2020)

Article Biochemistry & Molecular Biology

Identification of a New α-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening

Mingming Xu et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Article Chemistry, Medicinal

Protein Stability Effects in Aggregate-Based Enzyme Inhibition

Hayarpi Torosyan et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Multidisciplinary Sciences

Allele-selective lowering of mutant HTT protein by HTT-LC3 linker compounds

Zhaoyang Li et al.

NATURE (2019)

Article Multidisciplinary Sciences

SERF engages in a fuzzy complex that accelerates primary nucleation of amyloid proteins

Ben A. Meinen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Biochemistry & Molecular Biology

Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases

Alba Espargaro et al.

ACS CHEMICAL NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

Multistep Inhibition of α-Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine

Michele Perni et al.

ACS CHEMICAL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides

Baiping Ren et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Article Biochemistry & Molecular Biology

A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage

Michele F. M. Sciacca et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2018)

Review Clinical Neurology

Review: Relationship of type 2 diabetes to human brain pathology

J. J. Pruzin et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)

Review Biochemistry & Molecular Biology

Targeting Amyloid Aggregation: An Overview of Strategies and Mechanisms

Sofia Giorgetti et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Cell Biology

A new era for understanding amyloid structures and disease

Matthew G. Iadanza et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Multidisciplinary Sciences

SAR by kinetics for drug discovery in protein misfolding diseases

Sean Chia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Biochemistry & Molecular Biology

Tau Derived Hexapeptide AcPHF6 Promotes Beta-Amyloid (Aβ) Fibrillogenesis

Tarek Mohamed et al.

ACS CHEMICAL NEUROSCIENCE (2018)

Article Medicine, Research & Experimental

The diphenylpyrazole compound anle138b blocks A beta channels and rescues disease phenotypes in a mouse model for amyloid pathology

Ana Martinez Hernandez et al.

EMBO MOLECULAR MEDICINE (2018)

Article Biochemistry & Molecular Biology

High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors

Jordi Pujols et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Biochemistry & Molecular Biology

Sequence Specificity in the Entropy-Driven Binding of a Small Molecule and a Disordered Peptide

Gabriella T. Heller et al.

JOURNAL OF MOLECULAR BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding

I. Moreno-Gonzalez et al.

MOLECULAR PSYCHIATRY (2017)

Article Chemistry, Physical

Decreasing amyloid toxicity through an increased rate of aggregation

Silvia Sonzini et al.

PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2017)

Review Neurosciences

Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?

Yun Zhang et al.

PROGRESS IN NEUROBIOLOGY (2017)

Article Biochemistry & Molecular Biology

Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation

Emily H. Pilkington et al.

BIOMACROMOLECULES (2017)

Article Biochemistry & Molecular Biology

An in vivo platform for identifying inhibitors of protein aggregation

Janet C. Saunders et al.

NATURE CHEMICAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

The Luminescent Oligothiophene p-FTAA Converts Toxic Aβ1-42 Species into Nontoxic Amyloid Fibers with Altered Properties

Livia Civitelli et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Biochemistry & Molecular Biology

Polyphosphate: A Conserved Modifier of Amyloidogenic Processes

Claudia M. Cremers et al.

MOLECULAR CELL (2016)

Article Biochemical Research Methods

Molecular mechanisms of protein aggregation from global fitting of kinetic models

Georg Meisl et al.

NATURE PROTOCOLS (2016)

Article Chemistry, Multidisciplinary

Bisphenol analogues differently affect human islet polypeptide amyloid formation

Lizi Huang et al.

RSC ADVANCES (2016)

Article Chemistry, Multidisciplinary

Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation

Cong-Heng Chen et al.

RSC ADVANCES (2016)

Review Endocrinology & Metabolism

Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives

Amit Pithadia et al.

JOURNAL OF DIABETES RESEARCH (2016)

Article Pharmacology & Pharmacy

Spectroscopic analysis on the binding interaction of biologically active pyrimidine derivative with bovine serum albumin

Vishwas D. Suryawanshi et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2016)

Article Biochemistry & Molecular Biology

Inhibition of protein aggregation and amyloid formation by small molecules

Andrew J. Doig et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2015)

Review Biochemistry & Molecular Biology

Targeting disordered proteins with small molecules using entropy

Gabriella T. Heller et al.

TRENDS IN BIOCHEMICAL SCIENCES (2015)

Article Chemistry, Multidisciplinary

Monitoring and Targeting the Initial Dimerization Stage of Amyloid Self-Assembly

Yaron Bram et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

Article Chemistry, Multidisciplinary

Effects of Polyamino Acids and Polyelectrolytes on Amyloid β Fibril Formation

Anna Assarsson et al.

LANGMUIR (2014)

Review Cell Biology

The amyloid state and its association with protein misfolding diseases

Tuomas P. J. Knowles et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Article Multidisciplinary Sciences

Differences in nucleation behavior underlie the contrasting aggregation kinetics of the Aβ40 and Aβ42 peptides

Georg Meisl et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Biochemistry & Molecular Biology

Cellular Polyamines Promote Amyloid-Beta (Aβ) Peptide Fibrillation and Modulate the Aggregation Pathways

Jinghui Luo et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Article Clinical Neurology

Amylin Deposition in the Brain: A Second Amyloid in Alzheimer Disease?

Kaleena Jackson et al.

ANNALS OF NEUROLOGY (2013)

Article Chemistry, Multidisciplinary

Toward the Molecular Mechanism(s) by Which EGCG Treatment Remodels Mature Amyloid Fibrils

Fernando L. Palhano et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)

Article Multidisciplinary Sciences

Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism

Samuel I. A. Cohen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Biochemistry & Molecular Biology

Polythiophenes Inhibit Prion Propagation by Stabilizing Prion Protein (PrP) Aggregates

Ilan Margalith et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils

Jan Bieschke et al.

NATURE CHEMICAL BIOLOGY (2012)

Article Chemistry, Multidisciplinary

Two-dimensional infrared spectroscopy reveals the complex behaviour of an amyloid fibril inhibitor

Chris T. Middleton et al.

NATURE CHEMISTRY (2012)

Article Chemistry, Multidisciplinary

Small Molecule Modulators of Copper-Induced Aβ Aggregation

Sarmad S. Hindo et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)

Article Biochemistry & Molecular Biology

Small-molecule aggregates inhibit amyloid polymerization

Brian Y. Feng et al.

NATURE CHEMICAL BIOLOGY (2008)

Article Biochemistry & Molecular Biology

Methylene blue inhibits amyloid Aβ oligomerization by promoting fibrillization

Mihaela Necula et al.

BIOCHEMISTRY (2007)

Review Biochemistry & Molecular Biology

Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective

RE Tanzi et al.

Article Biochemistry & Molecular Biology

Cellular polyamines promote the aggregation of α-synuclein

T Antony et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)